← back to search

Marc Ansari

Western General Hospital · CH
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Hematopoietic Stem Cell Transplantation, and Pharmacogenetics and Drug Metabolism.
h-index
39
citations
5,979
works
321
NIH funding
primary concept
Medicine
email

Recent publications

Process Analysis of Time to Antibiotics in Pediatric Patients With Fever in Neutropenia During Chemotherapy for Cancer.
2026cited by 0position: contributordoi
Resilience in Parents of Childhood Cancer Survivors: Results From the Swiss Childhood Cancer Survivors Study-Parents.
2026cited by 0position: contributordoi
Multiple breath-washout for pulmonary function assessment in young childhood cancer survivors: a multicenter study.
2026cited by 0position: contributordoi
Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell Transplantation.
2026cited by 0position: contributordoi
Longitudinal Analysis of Psychological Distress in Grandparents of Children With Cancer: Results From a Multicenter Cohort Study in Switzerland (GROKids Project).
2026cited by 0position: contributordoi
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.
2026cited by 0position: contributordoi
Refining Busulfan Exposure Enhances Pediatric ALL HSCT Outcomes: Insights from the International FORUM Study.
2026cited by 0position: contributordoi
Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure
EJC Paediatric Oncology 2025cited by 5position: lastdoi
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group
Blood Advances 2025cited by 5position: middledoi
Assessing Pulmonary Function in Children and Adolescents After Cancer Treatment: Protocol for a Multicenter Cohort Study (Swiss Childhood Cancer Survivor Study FollowUp-Pulmo).
2025cited by 5position: contributordoi
Single-cell transcriptome analysis reveals atypical monocytes circulating ahead of acute graft-versus-host disease clinical onset.
2025cited by 3position: contributordoi
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group.
2025cited by 3position: contributordoi
A Health Service Research Study on a Low-Threshold Hearing Screening Program for Childhood Cancer Survivors in Switzerland: Protocol for the HEAR Study.
2025cited by 2position: contributordoi
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM.
2025cited by 2position: contributordoi
Pulmonary function in young childhood cancer survivors: results from a prospective multicentre cohort
2025cited by 1position: contributordoi
Hearing screening beyond the clinic: Childhood cancer survivors’ perspectives on a novel hearing screening program
2025cited by 1position: contributordoi
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP
Bone Marrow Transplantation 2025cited by 0position: middledoi
Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival – an EBMT PDWP retrospective study
Bone Marrow Transplantation 2025cited by 0position: middledoi
Comparison of outcomes in pediatric patients with acute leukemia undergoing allogeneic HLA-haploidentical hematopoietic stem cell transplantation (HSCT) after in vitro a/b T- and CD19-cell depletion or In Vivo administration of post-transplant cyclophosphamide: An EBMT pediatric working party study
Blood 2025cited by 0position: middledoi
Molecular Profiling of <i>SYT-SSX</i> Fusion Transcripts for Enhanced Diagnosis of Synovial Sarcomas.
2025cited by 0position: contributordoi
Multiple breath-washout for pulmonary function assessment in young childhood cancer survivors: a multicenter study
2025cited by 0position: contributordoi
Haplotype Inference Using Long-Read Nanopore Sequencing: Application to GSTA1 Promoter.
2025cited by 0position: contributordoi
Exercise-induced symptoms in young childhood cancer survivors
2025cited by 0position: contributordoi
Real-world outcomes of haplo-HSCT with post-transplant cyclophosphamide in pediatric hematologic malignancies: a study on behalf of SFGM-TC and SFCE.
2025cited by 0position: contributordoi
Financial Support and Income Satisfaction Among Grandparents of Childhood Cancer Patients: A Brief Report.
2025cited by 0position: contributordoi
Evaluation of a new, community-based screening program to detect hearing loss in adult childhood cancer survivors in Switzerland – Findings from the HEAR study
2025cited by 0position: contributordoi
Meeting the Challenges of Post-Transplant Lymphoproliferative Disorders After Liver Transplantation in Children: A Proposed Diagnostic and Management Algorithm.
2025cited by 0position: contributordoi
Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature
Journal of Clinical Oncology 2024cited by 22position: middledoi
Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature.
2024cited by 19position: contributordoi
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplantation 2024cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 48 papers (2019–2026)C. E. Kuehni · University of Bern34 papers (2019–2026)Christina Schindera · University of Bern18 papers (2020–2026)Nicolas Waespe · University of Geneva17 papers (2020–2026)Christina Peters · Nottingham City Hospital15 papers (2017–2025)Gisela Michel · Institute of Social and Preventive Medicine13 papers (2018–2026)Nicolas X. von der Weid · University Children’s Hospital Basel12 papers (2022–2026)André O. von Bueren · University Medical Center Hamburg-Eppendorf12 papers (2019–2024)Maša Žarković · University of Bern10 papers (2024–2026) · 10 papers (2019–2026)Luzius Mader · Schweizerische Ärztegesellschaft für Psycholytische Therapie9 papers (2021–2025)Fabiën N. Belle · University of Bern9 papers (2019–2023)Maria Otth · University of Lucerne9 papers (2019–2025)Tayfun Güngör · University Children's Hospital Zurich8 papers (2020–2025)Carina Nigg · Elsevier, Inc.8 papers (2024–2025)Sven Strebel · Institute of Social and Preventive Medicine8 papers (2021–2025)Tiago Nava · Universidade Federal do Rio Grande do Sul8 papers (2020–2023)Jochen Buechner · Université de Montréal8 papers (2020–2025)Henrique Bittencourt · Centre Hospitalier Universitaire Sainte-Justine7 papers (2017–2022)Grit Sommer · University of Bern7 papers (2019–2025)